Arcturus Therapeutics Holdings Inc. (ARCT)
NASDAQ: ARCT · Real-Time Price · USD
11.58
-0.42 (-3.50%)
At close: Mar 28, 2025, 4:00 PM
11.61
+0.03 (0.27%)
After-hours: Mar 28, 2025, 7:56 PM EDT
ARCT Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for ARCT stock have an average target of 57.8, with a low estimate of 41 and a high estimate of 70. The average target predicts an increase of 399.14% from the current stock price of 11.58.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for ARCT stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 3 | 3 |
| Buy | 4 | 4 | 4 | 4 | 4 | 4 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 7 | 8 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $74 → $68 | Strong Buy | Maintains | $74 → $68 | +487.22% | Mar 10, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $63 → $60 | Strong Buy | Maintains | $63 → $60 | +418.13% | Mar 7, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Mar 7, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $58 → $50 | Buy | Maintains | $58 → $50 | +331.78% | Mar 7, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $63 | Strong Buy | Reiterates | $63 | +444.04% | Feb 18, 2025 |
Financial Forecast
Revenue This Year
178.24M
from 152.31M
Increased by 17.02%
Revenue Next Year
326.20M
from 178.24M
Increased by 83.01%
EPS This Year
-2.19
from -3.00
EPS Next Year
0.34
from -2.19
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 260.3M | 937.9M | 1.4B | ||
| Avg | 178.2M | 326.2M | 514.8M | ||
| Low | 88.8M | 141.2M | 269.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 70.9% | 426.2% | 343.9% | ||
| Avg | 17.0% | 83.0% | 57.8% | ||
| Low | -41.7% | -20.8% | -17.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.28 | 9.50 | 20.56 | ||
| Avg | -2.19 | 0.34 | 3.60 | ||
| Low | -5.05 | -5.66 | -4.84 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | 5,952.8% | ||
| Avg | - | - | 961.1% | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.